These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29492379)

  • 1. Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis.
    Theochari CA; Michalopoulos G; Oikonomou EK; Giannopoulos S; Doulamis IP; Villela MA; Kokkinidis DG
    Ann Cardiothorac Surg; 2018 Jan; 7(1):3-11. PubMed ID: 29492379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous-flow left ventricular assist device versus orthotopic heart transplantation in adults with heart failure: a systematic review and meta-analysis.
    Zhang B; Guo S; Ning J; Li Y; Liu Z
    Ann Cardiothorac Surg; 2021 Mar; 10(2):209-220. PubMed ID: 33842215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor.
    Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT
    J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.
    Nakagawa S; Garan AR; Takayama H; Takeda K; Topkara VK; Yuzefpolskaya M; Lin SX; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2018 Sep; 21(9):1284-1289. PubMed ID: 29874117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients.
    Miller RJH; Moayedi Y; Sharma A; Haddad F; Hiesinger W; Banerjee D
    ASAIO J; 2020 Apr; 66(4):394-398. PubMed ID: 31192848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Palliative care in patients with left ventricular assist devices: systematic review].
    Tenge T; Schlieper D; Schallenburger M; Meier S; Schwartz J; Neukirchen M
    Anaesthesist; 2021 Dec; 70(12):1044-1050. PubMed ID: 33931802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Continuous Flow Left Ventricular Assist Device on Heart Transplant Candidates: A Multi-State Survival Analysis.
    Carrozzini M; Bottio T; Caraffa R; Bejko J; Bifulco O; Guariento A; Lombardi CM; Metra M; Azzolina D; Gregori D; Fedrigo M; Castellani C; Tarzia V; Toscano G; Gambino A; Jorgji V; Ferrari E; Angelini A; Gerosa G
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
    Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proposal for updated listing criteria for heart transplantation and indications to implant of left ventricular assist devices].
    Ammirati E; Oliva F; Colombo T; Botta L; Cipriani M; Cannata A; Verde A; Turazza FM; Russo CF; Paino R; Martinelli L; Frigerio M
    G Ital Cardiol (Rome); 2013 Feb; 14(2):110-9. PubMed ID: 23389313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.